Search Results

TG-101348 10mg 10mg  | Purity Not Available

Adooq Bioscience

TG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.

More Information Supplier Page

CCT137690 50mg 50mg  | Purity Not Available

Adooq Bioscience

CCT137690 is a potent inhibitor of Aurora kinases that inhibits Aurora A and B kinases with low nanomolar IC50 values in both biochemical and cellular assays.

More Information Supplier Page

CCT137690 5mg 5mg  | Purity Not Available

Adooq Bioscience

CCT137690 is a potent inhibitor of Aurora kinases that inhibits Aurora A and B kinases with low nanomolar IC50 values in both biochemical and cellular assays.

More Information Supplier Page

JTC-801 10mg 10mg  | Purity Not Available

Adooq Bioscience

JTC-801 is a selective antagonist for the nociceptin receptor, also known as the ORL-1 receptor.

More Information Supplier Page

AZD4547 50mg 50mg  | Purity Not Available

Adooq Bioscience

AZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.

More Information Supplier Page

AZD4547 5mg 5mg  | Purity Not Available

Adooq Bioscience

AZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.

More Information Supplier Page

AZD4547 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

AZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.

More Information Supplier Page

AZD4547 100mg 100mg  | Purity Not Available

Adooq Bioscience

AZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.

More Information Supplier Page